(Q46743813)

English

Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

0 references

0 references

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

author name string

Timothy J Vittorio

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

Ronald Zolty

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

Michael E Kasper

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

Raj M Khandwalla

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

David S Hirsh

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

Chi-Hong Tseng

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

Ulrich P Jorde

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

Kartikya Ahuja

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

Journal of Cardiovascular Pharmacology and Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

13

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

51-57

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Reproducibility and consistency of the responses to supine bicycle ergometry; evaluation in conjunction with beta 1-adrenoceptor occupancies

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Endothelin in neurohormonal activation in heart failure

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Reduced exercise tolerance in chronic heart failure and its relationship to neurohumoral factors

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Differing beta-blocking effects of carvedilol and metoprolol

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure?

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Clinical pharmacokinetics of metoprolol

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprolol

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients.

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Polymorphic metabolism of beta-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Pharmacogenetics of beta-1- and beta-2-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Pharmacokinetics and pharmacodynamics of beta blockers in heart failure

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312629

21 January 2018

Identifiers

10.1177/1074248407312629

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287590

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46743813&oldid=2129570708"